USPTO serial 78321806
KINEMED
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- STEIN, JAMES W
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with KINEMED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Emeryville, CA
Emeryville, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kristin Manley
Kristin Manley COOLEY GODWARD KRONISH LLP101 CALIFORNIA STREET, 5TH FLOORSAN FRANCISCO, CA 94111-5800UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, rheumatoid arthritis, and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of psychiatric or cognitive disorders, namely, mood disorders, anxiety disorders, and disorders of learning and memory; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, and metabolic syndrome; pharmaceutical preparations for the treatment of cardiovascular diseases, namely, coronary artery disease, congestive heart failure, and cardiomyopathy; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory connective tissue diseases, inflammatory bowel disease, osteoarthritis, and wound healing; pharmaceutical preparations for the treatment of neurologic diseases, namely, multiple sclerosis, Alzheimer's disease, Parkinson's disease, and cognitive disorders; pharmaceutical preparations for the treatment of dermatologic diseases, namely, psoriasis, atopic dermatitis, eczema, photowrinkling and aging, and skin pigmentation disorders; pharmaceutical preparations for the treatment of disorders relating to toxicological insult, namely, liver cirrhosis, liver fibrosis, and pulmonary fibrosis; pharmaceutical preparations for the treatment of reproductive disorders, namely, male infertility and female infertility; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, and cartilage degradation; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in cardiology; pharmaceutical preparations for use in gynecology and urology; pharmaceutical preparations for use in endocrinology; pharmaceutical preparations for use in rheumatology; pharmaceutical preparations for use in neurology; pharmaceutical preparations for use in allergies and infectious diseases (immunology); pharmaceutical preparations for use in gerontology. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 12, 2008 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 12, 2008 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 29, 2007 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 29, 2007 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 29, 2007 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 9, 2007 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 7, 2007 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 7, 2007 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 7, 2007 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 22, 2007 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 27, 2006 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 27, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 10, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 12, 2006 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 30, 2006 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 30, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 5, 2005 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 18, 2005 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 18, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 7, 2005 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 15, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 23, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 30, 2004 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 17, 2004 | ALIE | ASSIGNED TO LIE | — |
| Dec 13, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 10, 2004 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 6, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 6, 2004 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 9, 2004 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 24, 2003 | NWAP | NEW APPLICATION ENTERED | — |